[1] Jia F, Tian J, Deng F, et al. Subclinical hypothyroidism and the associations with macrovascular complications and chronic kidney disease in patients with Type 2 diabetes[J]. Diabet Med, 2015, 32(8):1097-1103. [2] Chen H S, Wu T E, Jap T S, et al. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients[J]. Diabet Med, 2007, 24(12):1336-1344. [3] Aronow W S. Peripheral arterial disease[J]. Geriatrics, 2007, 62(1):19-25. [4] Mya M M, Aronow W S. Increased prevalence of peripheral arterial disease in older men and women with subclinical hypothyroidism[J]. J Gerontol A Biol Sci Med Sci, 2003, 58(1):68-69. [5] 刘薇, 华琳, 原晶, 等.亚临床甲状腺功能减退对老年人2型糖尿病大血管并发症的影响[J]. 中华老年医学杂志, 2015, 34(12):1333-1337. [6] Alberti K G, Zimmet P Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J]. Diabet Med, 1998, 15(7):539-553. [7] Sacks D, Bakal C W, Beatty P T, et al. Position statement on the use of the ankle-brachial index in the evaluation of patients with peripheral vascular disease:a consensus statement developed by the standards division of the society of cardiovascular & interventional radiology[J]. J Vasc Interv Radiol,2002, 13(4):353. [8] 中华医学会糖尿病学分会. 2型糖尿病患者合并下肢动脉病变的筛查及管理规范[J]. 中华糖尿病杂志, 2013, 5(2):82-88. [9] 中华医学会内分泌学分会《中国甲状腺疾病诊治指南》编写组. 甲状腺疾病诊治指南——甲状腺功能减退症[J]. 中华内科杂志, 2007, 46(11):967-971. [10] Levey A S, Stevens L A, Schmid C H, et al. A new equation to estimate glomerular filtration rate[J]. Ann Intern Med, 2009, 150(9):604-612. [11] Floriani C, Gencer B, Collet T H, et al. Subclinical thyroid dysfunction and cardiovascular diseases:2016 update[J]. Eur Heart J, 2018, 39(7):503-507. [12] Mora C, Navarro J F. The role of inflammation as a pathogenic factor in the development of renal disease in diabetes[J]. Curr Diab Rep, 2005, 5(6):399-401. [13] Marchiori R C, Pereira L A, Naujorks A A, et al. Improvement of blood inflammatory marker levels in patients with hypothyroidism under levothyroxine treatment[J]. BMC Endocr Disord, 2015, 15:32. [14] Han C, He X, Xia X, et al. Subclinical hypothyroidism and type 2 diabetes:a systematic review and meta-analysis[J]. PLoS One, 2015, 10(8):e0135233. [15] Pandrc M S, Ristic A, Kostovski V, et al. The effect of early substitution of subclinical hypothyroidism on biochemical blood parameters and the quality of life[J]. J Med Biochem, 2017, 36(2):127-136. [16] Mazzeffi M A, Lin H M, Flynn B C, et al. Hypothyroidism and the risk of lower extremity arterial disease[J]. Vasc Health Risk Manag, 2010, 6:957-962. [17] Park Y J, Lee Y J, Choi S I, et al. Impact of subclinical hypothyroidism on the coronary artery disease in apparently healthy subjects[J]. Eur J Endocrinol, 2011, 165(1):115-121. |